Delivery Order SPE2DR25D2006-SPE2DR26F56RF
- Not listed
- The Defense Logistics Agency awarded a $12,063.51 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Adderall 10 mg tablets (100-count units), with an ultimate completion date of December 8, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,278.00 to AmerisourceBergen Drug Corp for the supply of Adderall 10 mg tablets (100 count units) on November 14, 2025, with an ultimate completion date of November 17, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (100-count units) under a firm fixed-price contract valued at $23,466.37, with an ultimate completion date of December 9, 2025. This competitively awarded, non-set-aside delivery order supports the federal government's pharmaceutical supply needs for military and related healthcare systems. The place of performance is located in Conshohocken, Pennsylvania, where...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $6,506.42 for the supply of Adderall tablets, 10 mg strength, to support the Defense Medical Supply Chain. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by September 30, 2025. The award represents a child delivery order issued under AmerisourceBergen's broader Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Adderall 10 mg tablets (100-count) valued at $1,225.66. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of December 4, 2025. The award was made without a set-aside designation, demonstrating the contractor's ability to compete in open federal procurement. The place...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,646.74 to AmerisourceBergen Drug Corp for the supply of Adderall 20 mg tablets (100-count units) under a firm fixed price contract. This non-set-aside delivery order, issued on December 8, 2025, with completion targeted for December 9, 2025, will be fulfilled from the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 20 mg tablets (100-count units) under a firm fixed-price contract valued at $4,431.07, with an ultimate completion date of October 31, 2025. This competitively awarded, non-set-aside delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement needs. The order will be fulfilled from the company's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 10 mg tablets (100-count units) with a contract ceiling value of $3,931.85. This competitively awarded, non-set-aside delivery order was executed on October 27, 2025, with an ultimate completion date of October 28, 2025, and reflects firm fixed pricing. The work is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $3,631.72 to AmerisourceBergen Drug Corp for the supply of Adderall XR 30 mg capsules (100-count units) on October 27, 2025, with an ultimate completion date of October 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,798.06 to AmerisourceBergen Drug Corp for the supply of Adderall 20 mg tablets (100 count units). This firm fixed-price delivery order, awarded on April 24, 2025, represents a non-set-aside competitive procurement with an ultimate completion date of April 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F56RFDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 30 mg tablets (100 count units) with a ceiling value of $6,187.04. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by December 11, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations. This delivery order represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999.999 billion through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies a broad range of medications and medical commodities to support military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling pharmaceutical requirements across multiple therapeutic domains through competitively awarded delivery orders with consistent firm fixed pricing structures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 12/9/25 |